Using microneedle arrays developed at Carnegie Melon, microdosed with a known chemotherapeutic agent delivered directly to ...

Genetics in Medicine - Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory Skip to main content Thank you for visiting nature.com.

npj Genomic Medicine - Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy Skip to main content Thank you for visiting nature.com.

Concurrent multiple odontogenic keratocysts and odontogenic myxoma in a patient with nevoid basal cell carcinoma: a case report and literature review, Oral Surgery, Oral Medicine, Oral Pathology ...

To the Editor: The excellent review by Rubin et al. of basal-cell carcinoma (Nov. 24 issue) 1 considers the genital area an unusual site for basal-cell carcinomas. In our view, this site ...

Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002–2006 and 2007–2011. American Journal of Preventive Medicine. February 2015. Basal Cell Carcinoma Risk Factors.

In response to primary basal cell medium, NKX2-1 GFP+ /TP63 tdTomato+ cells display the molecular and functional phenotype of airway basal cells, including the capacity to self-renew or undergo ...

View list of generic and brand names of drugs used for treatment of Basal Cell Cancer of the Skin( Rodent Ulcer , Tear Cancer). Find more information including dose, side effects of the Basal Cell ...

Health & Medicine; Why basal cell tumours return when drug treatment stops. 03 Feb 2018. 1. What happens when the most common and least threatening type of cancer gets complicated?

Basal metabolic rate (BMR), is the rate of metabolism that occurs when an individual is at rest in a warm environment and is in the post absorptive state, and has not eaten for at least 12 hours.